| Characteristics | Tamoxifen users who had ever used ginseng (%) |
Tamoxifen users who had never used TCMa (%) | aORb (95% CIc) |
| Number of cases | 13,502 | 17,031 | | Number of endometrial cancers | 74 | 107 | | Age at diagnosis of breast cancer | | | | Average | 50.1 ± 10.8 | 52.4 ± 11.8 | | 20~29 yrs | 193 (1.4) | 194 (1.1) | 1 | 30~39 yrs | 1,896 (14.0) | 1,987 (11.7) | 0.87 (0.70–1.08) | 40~49 yrs | 5,099 (37.8) | 5,711 (33.5) | 0.81 (0.66–1.00) | 50~59 yrs | 3,551 (26.3) | 4,468 (26.2) | 0.75 (0.61–0.92) | 60~69 yrs | 2,005 (14.8) | 2,903 (17.0) | 0.65 (0.53–0.81) | 70~79 yrs | 758 (5.6) | 1,768 (10.4) | 0.43 (0.34–0.54) | Insured salary ($NT/month) | | | | 0 | 2,337 (17.3) | 3,636 (21.3) | 1 | 1–19999 | 7,160 (53.0) | 8,863 (52.0) | 1.12 (1.05–1.19) | 20000–39999 | 2,663 (19.7) | 3,081 (18.1) | 1.22 (1.13–1.32) | >=40000 | 1,342 (9.9) | 1,451 (8.5) | 1.32 (1.20–1.45) | Insured region | | | | Northern Taiwan | 6,593 (48.8) | 9,766 (57.3) | 1 | Central Taiwan | 2,827 (20.9) | 2,375 (13.9) | 1.89 (1.77–2.01) | Southern Taiwan | 3,643 (27.0) | 4,323 (25.4) | 1.28 (1.21–1.36) | Eastern Taiwan | 287 (2.1) | 354 (2.1) | 1.23 (1.05–1.45) | Outlying islands | 152 (1.1) | 215 (1.3) | 1.06 (0.86–1.32) | Duration of tamoxifen treatment | | | | <2 y | 6,524 (48.3) | 11,411 (67.0) | 1 | 2–4 y | 5,908 (43.8) | 4,756 (27.9) | 2.15 (2.05–2.26) | 5–7 y | 983 (7.3) | 773 (4.5) | 2.20 (1.99–2.44) | >=8 y | 87 (0.6) | 91 (0.5) | 1.69 (1.26–2.28) | Cancer treatment modalities | | | | Tamoxifen only | 190 (1.4) | 386 (2.3) | 1 | Tamoxifen and chemotherapy | 290 (2.1) | 777 (4.6) | 0.70 (0.56–0.87) | Tamoxifen plus surgery | 3,514 (26.0) | 4,569 (26.8) | 1.21 (1.01–1.46) | Tamoxifen, surgery, plus chemotherapy | 9,508 (70.4) | 11,299 (66.3) | 1.22 (1.02–1.47) |
|
|